Shanthi Mogali

1.5k total citations · 1 hit paper
18 papers, 1.0k citations indexed

About

Shanthi Mogali is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Epidemiology. According to data from OpenAlex, Shanthi Mogali has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 7 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Shanthi Mogali's work include Opioid Use Disorder Treatment (12 papers), Pain Mechanisms and Treatments (6 papers) and Substance Abuse Treatment and Outcomes (6 papers). Shanthi Mogali is often cited by papers focused on Opioid Use Disorder Treatment (12 papers), Pain Mechanisms and Treatments (6 papers) and Substance Abuse Treatment and Outcomes (6 papers). Shanthi Mogali collaborates with scholars based in United States, Italy and France. Shanthi Mogali's co-authors include Sandra D. Comer, Jermaine D. Jones, Jeffrey Gudin, Jeanne M. Manubay, Maria A. Sullivan, Verena E. Metz, Suzanne K. Vosburg, Roberto Ciccocioppo, Perrine Roux and Kirk W. Johnson and has published in prestigious journals such as Pain, Neuropsychopharmacology and Physiology & Behavior.

In The Last Decade

Shanthi Mogali

18 papers receiving 996 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polydrug abuse: A review of opioid and benzodiazepine combination use

2012 522 citations Jermaine D. Jones, Shanthi Mogali et al. Drug and Alcohol Dependence profile →

Peers

Shanthi Mogali

PHEOH

EPIDE

CMN

PHARM

APM

Marc Vogel Switzerland

Paul A. Nuzzo United States

Andrew S. Huhn United States

Kirk E. Evoy United States

Emily B. Einstein United States

Jenny Bearn United Kingdom

Paul Casadonte United States

Jeanne M. Manubay United States

Myroslava K. Romach Canada

Eric Wargo United States

Marc Vogel Switzerland

Shanthi Mogali

492 ×0.9

PHEOH

330 ×1.1

EPIDE

131 ×0.6

CMN

173 ×0.9

PHARM

166 ×0.9

APM

Citations per year, relative to Shanthi Mogali Shanthi Mogali (= 1×) peers Marc Vogel

Countries citing papers authored by Shanthi Mogali

Since Specialization

Citations

This map shows the geographic impact of Shanthi Mogali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanthi Mogali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanthi Mogali more than expected).

Fields of papers citing papers by Shanthi Mogali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanthi Mogali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanthi Mogali. The network helps show where Shanthi Mogali may publish in the future.

Co-authorship network of co-authors of Shanthi Mogali

This figure shows the co-authorship network connecting the top 25 collaborators of Shanthi Mogali. A scholar is included among the top collaborators of Shanthi Mogali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanthi Mogali. Shanthi Mogali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Castillo, Felipe, Jermaine D. Jones, Shanthi Mogali, et al.. (2022). Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder. Pharmacology Biochemistry and Behavior. 221. 173482–173482. 3 indexed citations

Jones, Jermaine D., Nehal P. Vadhan, Jeanne M. Manubay, et al.. (2022). The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine’s effects. Behavioural Pharmacology. 33(4). 255–265. 4 indexed citations

Mogali, Shanthi, et al.. (2021). Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users. Pharmacology Biochemistry and Behavior. 209. 173241–173241. 11 indexed citations

Brandt, Laura, Jermaine D. Jones, Jeanne M. Manubay, et al.. (2020). Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder. Drug and Alcohol Dependence. 208. 107859–107859. 26 indexed citations

Jones, Jermaine D., et al.. (2019). Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. Pharmacology Biochemistry and Behavior. 186. 172778–172778. 11 indexed citations

Jones, Jermaine D., Adam Bisaga, Verena E. Metz, et al.. (2018). The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety. Journal of Psychoactive Drugs. 50(5). 390–401. 21 indexed citations

Jones, Jermaine D., et al.. (2017). Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount. Drug and Alcohol Dependence. 179. 362–369. 17 indexed citations

Metz, Verena E., Jermaine D. Jones, Jeanne M. Manubay, et al.. (2017). Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence. Neuropsychopharmacology. 42(9). 1825–1832. 61 indexed citations

Jones, Jermaine D., Sandra D. Comer, Verena E. Metz, et al.. (2017). Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential. Pharmacology Biochemistry and Behavior. 163. 90–100. 28 indexed citations

10.

Jones, Jermaine D., Maria A. Sullivan, Jeanne M. Manubay, et al.. (2015). The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users. Physiology & Behavior. 159. 33–39. 21 indexed citations

11.

Mogali, Shanthi, et al.. (2015). Baseline characteristics of patients predicting suitability for rapid naltrexone induction. American Journal on Addictions. 24(3). 258–264. 12 indexed citations

12.

Manubay, Jeanne M., Sandra D. Comer, Shanthi Mogali, et al.. (2015). Patterns of opioid use and co-morbidity in non-treatment-seeking individuals with opioid use disorder. Drug and Alcohol Dependence. 156. e139–e139. 3 indexed citations

13.

Jones, Jermaine D., Maria A. Sullivan, Suzanne K. Vosburg, et al.. (2014). Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine‐maintained heroin users. Addiction Biology. 20(4). 784–798. 27 indexed citations

14.

Mogali, Shanthi, Jermaine D. Jones, Jeanne M. Manubay, Maria A. Sullivan, & Sandra D. Comer. (2014). Effects of minocycline on oxycodone-induced responses in humans. Drug and Alcohol Dependence. 140. e153–e153. 4 indexed citations

15.

Comer, Sandra D., Shanthi Mogali, Phillip Saccone, et al.. (2013). Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers. Neuropsychopharmacology. 38(12). 2427–2438. 45 indexed citations

16.

Roux, Perrine, Maria A. Sullivan, Julien Cohen, et al.. (2013). Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain. 154(8). 1442–1448. 40 indexed citations

17.

Gudin, Jeffrey, Shanthi Mogali, Jermaine D. Jones, & Sandra D. Comer. (2013). Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use. Postgraduate Medicine. 125(4). 115–130. 173 indexed citations

18.

Jones, Jermaine D., Shanthi Mogali, & Sandra D. Comer. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence. 125(1-2). 8–18. 522 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact